WHO Withdrawal, CGT Access, IRA: Trump’s Initial Policies Raise Questions for Biopharma

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, President Trump issued multiple executive orders that concern the industry.